Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Denali Therapeutics Inc (NQ: DNLI ) 19.93 -0.20 (-0.97%) Streaming Delayed Price Updated: 12:05 PM EDT, May 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 131,786 Open 20.05 Bid (Size) 19.92 (1) Ask (Size) 19.95 (4) Prev. Close 20.13 Today's Range 19.86 - 20.50 52wk Range 14.56 - 33.31 Shares Outstanding 121,640,069 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday May 08, 2024 Via Benzinga DNLI Stock Earnings: Denali Therapeutics Beats EPS for Q1 2024 May 07, 2024 DNLI stock results show that Denali Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Performance YTD -6.80% -6.80% 1 Month +24.67% +24.67% 3 Month +20.53% +20.53% 6 Month +3.88% +3.88% 1 Year -36.73% -36.73% More News Read More Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights May 07, 2024 From Denali Therapeutics Inc. Via GlobeNewswire 4 Analysts Assess Denali Therapeutics: What You Need To Know February 28, 2024 Via Benzinga Denali Therapeutics: Q4 Earnings Insights February 27, 2024 Via Benzinga The Latest Analyst Ratings for Denali Therapeutics December 13, 2023 Via Benzinga Where Denali Therapeutics Stands With Analysts November 08, 2023 Via Benzinga Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial May 01, 2024 From Denali Therapeutics Inc. Via GlobeNewswire To the Moon and Beyond: 7 Stocks With Cosmic Potential March 14, 2024 Via InvestorPlace Goldman Sachs Maintains Buy Rating for Denali Therapeutics: Here's What You Need To Know February 29, 2024 Via Benzinga Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday February 27, 2024 Via Benzinga Topics Stocks Exposures US Equities Analyst Expectations for Denali Therapeutics's Future August 31, 2023 Via Benzinga Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 27, 2024 Via Benzinga Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights February 27, 2024 From Denali Therapeutics Inc. Via GlobeNewswire Denali Therapeutics Announces $500 million Private Placement Equity Financing February 27, 2024 From Denali Therapeutics Inc. Via GlobeNewswire Gene Therapy Player REGENXBIO's RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst February 12, 2024 Via Benzinga 3 Biotech Stocks to Buy for the Next Bull Run: February 2024 February 08, 2024 Via InvestorPlace Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™ February 07, 2024 From Denali Therapeutics Inc. Via GlobeNewswire Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™ February 01, 2024 From Denali Therapeutics Inc. Via GlobeNewswire Denali Therapeutics Announces Key Anticipated 2024 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases January 08, 2024 From Denali Therapeutics Inc. Via GlobeNewswire 3 Biotech Stocks at the Forefront of the Quest for Eternal Youth January 02, 2024 Via InvestorPlace Denali Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights November 07, 2023 From Denali Therapeutics Inc. Via GlobeNewswire Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday November 03, 2023 Via Benzinga Topics Stocks Exposures US Equities Denali Therapeutics Breakthrough Blood-Brain Barrier Platform A Game-Changer in Neurodegenerative Diseases: Analyst September 06, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 September 06, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
